Drug Safety
Warfarin and Risk of Hip and Knee Replacements: Dr. Mrinalini Dey
Dr. Mrinalini Dey reviews abstract #0934 presented Saturday at the 2020 ACR annual meeting.
Warfarin and End-Stage Osteoarthritis: Dr. David Liew
Dr. David Liew discusses abstract #0934 presented at the 2020 ACR annual meeting.
SEAM-RA Trial: Dr. Jeff Curtis
Dr. Jeff Curtis discusses abstract #0939, which looked at whether RA patients at or close to remission should continue taking their combination therapy, as presented at ACR 2020.
HCQ and QTc Prolongation: Dr David Liew
Dr. David Liew reviews abstracts #0431 presented at the ACR 2020 annual meeting - and shares the results of the Twitter poll he conducted asking when prescribing HCQ, is an EKG routinely ordered either before or doing.
Safety of JAKs: Venous Thromboembolic Risk: Dr. Kevin Winthrop
OHSU rheumatologist Dr. Kevin Winthrop in Portland looks at two posters -- abstracts #0215 and #0229 presented Friday at ACR 2020.
Methotrexate Induced Liver Fibrosis: Dr. Sheila Reyes
Dr. Sheila Reyes discusses abstract #0205 presented Friday at the 2020 ACR annual meeting.
Methotrexate and Nonalcoholic Fatty Liver Disease: Dr Eric Dein
Dr. Eric Dein discusses the findings of abstract #0181 at the ACR 2020 annual meeting.
Spondyloarthritis at ACR 2020: Dr. Lianne Gensler
San Francisco-based rheumatologist Dr. Lianne Gensler examines a wide range of spondyloarthritis topics at ACR 2020, including how to join up with others interested in spondyloarthritis; enthesitis; the utility of MRI for the diagnosis for axSpA; novel treatments; and the impact of drugs on disease modification.
Poster Hall